Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

2.2K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
2.2K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.5K
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corona: A Virtual Mass Spectrometer for the Development of Real-Time Mass Spectrometry Software.

Analytical chemistry·2026
Same author

Chromatin architectures underlying plasmid-based assays for regulatory variant effects.

Molecular cell·2026
Same author

Mitochondrial respiratory capacity in kidney podocytes is high, age-dependent, and sexually dimorphic.

Kidney international·2026
Same author

A unified photosensitizer platform for <i>in situ</i> DNA-, RNA-, and protein-directed proximity labeling.

bioRxiv : the preprint server for biology·2026
Same author

Multimodal analysis of molecular remodeling in aging spleen identified global and cell type specific changes.

bioRxiv : the preprint server for biology·2026
Same author

The proteomic landscape and temporal dynamics of human and mouse gastruloid development.

Nature cell biology·2026

Related Experiment Video

Updated: Apr 6, 2026

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

11.3K

Quantitative interactome analysis reveals a chemoresistant edgotype.

Juan D Chavez1, Devin K Schweppe1, Jimmy K Eng1

  • 1Department of Genome Sciences, University of Washington, Seattle, Washington 98195, USA.

Nature Communications
|August 4, 2015
PubMed
Summary

Understanding how cancer cells develop chemoresistance is crucial. This study used chemical crosslinking and mass spectrometry to analyze protein changes, revealing key alterations in protein interactions and structures linked to drug resistance in carcinoma cells.

More Related Videos

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
09:58

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

14.5K
Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
14:51

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

3.7K

Related Experiment Videos

Last Updated: Apr 6, 2026

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

11.3K
Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
09:58

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

14.5K
Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
14:51

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

3.7K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Proteomics

Background:

  • Chemoresistance is a primary cause of cancer therapy failure.
  • Proteins play critical roles in cancer cells developing resistance to chemotherapeutics.
  • Understanding protein structural and interaction changes is key to overcoming chemoresistance.

Purpose of the Study:

  • To investigate protein structural and interaction network changes in multidrug-resistant human carcinoma cells.
  • To apply chemical crosslinking and mass spectrometry for proteomic-scale analysis of chemoresistance.

Main Methods:

  • Utilized chemical crosslinking and mass spectrometry (MS) to analyze protein structure and interactions.
  • Quantified changes in a large protein interaction network derived from crosslinking data (1,391 crosslinked peptides).
  • Performed 'edgotype' analysis on the protein interaction network in a chemoresistance cell model.

Main Results:

  • Detected consistent alterations in protein interactions and structures correlating with a chemoresistant phenotype.
  • Identified specific proteins with altered structures and interactions, including cytokeratins, topoisomerase-2-alpha, and modified histones.
  • Established a link between proteomic network changes and the development of multidrug resistance.

Conclusions:

  • Chemical crosslinking and MS provide a powerful tool to study protein network adaptations in cancer.
  • Specific protein interaction and structural changes are associated with chemoresistance.
  • This approach offers insights into mechanisms of therapy failure and potential therapeutic targets.